Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF.

Wang S, Hesse B, Roman M, Stier D, Castillo-Michel H, Cotte M, Suuronen JP, Lagrange A, Radbruch H, Paul F, Taupitz M, Schellenberger E, Sack I, Infante-Duarte C.

Invest Radiol. 2019 Apr 26. doi: 10.1097/RLI.0000000000000571. [Epub ahead of print]

PMID:
31033673
2.

Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel.

Reichhart N, Schöberl S, Keckeis S, Alfaar AS, Roubeix C, Cordes M, Crespo-Garcia S, Haeckel A, Kociok N, Föckler R, Fels G, Mataruga A, Rauh R, Milenkovic VM, Zühlke K, Klussmann E, Schellenberger E, Strauß O.

Sci Rep. 2019 Feb 19;9(1):2257. doi: 10.1038/s41598-018-37287-y.

3.

Gadolinium in human brain sections and colocalization with other elements.

El-Khatib AH, Radbruch H, Trog S, Neumann B, Paul F, Koch A, Linscheid MW, Jakubowski N, Schellenberger E.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 19;6(1):e515. doi: 10.1212/NXI.0000000000000515. eCollection 2019 Jan. No abstract available.

4.

Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.

Ariza de Schellenberger A, Poller WC, Stangl V, Landmesser U, Schellenberger E.

Int J Nanomedicine. 2018 Nov 23;13:7905-7913. doi: 10.2147/IJN.S179920. eCollection 2018.

5.

Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon Catheters.

Speck U, Häckel A, Schellenberger E, Kamann S, Löchel M, Clever YP, Peters D, Scheller B, Trog S, Bettink S.

Cardiovasc Intervent Radiol. 2018 Oct;41(10):1599-1610. doi: 10.1007/s00270-018-2018-9. Epub 2018 Jul 2.

6.

Application of Europium-Doped Very Small Iron Oxide Nanoparticles to Visualize Neuroinflammation with MRI and Fluorescence Microscopy.

Millward JM, Ariza de Schellenberger A, Berndt D, Hanke-Vela L, Schellenberger E, Waiczies S, Taupitz M, Kobayashi Y, Wagner S, Infante-Duarte C.

Neuroscience. 2019 Apr 1;403:136-144. doi: 10.1016/j.neuroscience.2017.12.014. Epub 2017 Dec 19.

PMID:
29273325
7.

Synthesis of europium-doped VSOP, customized enhancer solution and improved microscopy fluorescence methodology for unambiguous histological detection.

de Schellenberger AA, Hauptmann R, Millward JM, Schellenberger E, Kobayashi Y, Taupitz M, Infante-Duarte C, Schnorr J, Wagner S.

J Nanobiotechnology. 2017 Oct 10;15(1):71. doi: 10.1186/s12951-017-0301-6.

8.

Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.

Boehm-Sturm P, Haeckel A, Hauptmann R, Mueller S, Kuhl CK, Schellenberger EA.

Radiology. 2018 Feb;286(2):537-546. doi: 10.1148/radiol.2017170116. Epub 2017 Sep 7.

PMID:
28880786
9.

LA-ICP-MS Allows Quantitative Microscopy of Europium-Doped Iron Oxide Nanoparticles and is a Possible Alternative to Ambiguous Prussian Blue Iron Staining.

Scharlach C, Müller L, Wagner S, Kobayashi Y, Kratz H, Ebert M, Jakubowski N, Schellenberger E.

J Biomed Nanotechnol. 2016 May;12(5):1001-10.

PMID:
27305821
10.

XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic.

Haeckel A, Appler F, Ariza de Schellenberger A, Schellenberger E.

PLoS One. 2016 Jun 13;11(6):e0157193. doi: 10.1371/journal.pone.0157193. eCollection 2016.

11.

Labeling of mesenchymal stem cells for MRI with single-cell sensitivity.

Ariza de Schellenberger A, Kratz H, Farr TD, Löwa N, Hauptmann R, Wagner S, Taupitz M, Schnorr J, Schellenberger EA.

Int J Nanomedicine. 2016 Apr 12;11:1517-35. doi: 10.2147/IJN.S101141. eCollection 2016.

12.

Determination of blood circulation times of superparamagnetic iron oxide nanoparticles by T2* relaxometry using ultrashort echo time (UTE) MRI.

Scharlach C, Warmuth C, Schellenberger E.

Magn Reson Imaging. 2015 Nov;33(9):1173-1177. doi: 10.1016/j.mri.2015.06.017. Epub 2015 Jun 26.

PMID:
26119420
13.

Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining.

Scharlach C, Kratz H, Wiekhorst F, Warmuth C, Schnorr J, Genter G, Ebert M, Mueller S, Schellenberger E.

Nanomedicine. 2015 Jul;11(5):1085-95. doi: 10.1016/j.nano.2015.01.002. Epub 2015 Feb 4.

PMID:
25659644
14.

Monitoring stroke progression: in vivo imaging of cortical perfusion, blood-brain barrier permeability and cellular damage in the rat photothrombosis model.

Schoknecht K, Prager O, Vazana U, Kamintsky L, Harhausen D, Zille M, Figge L, Chassidim Y, Schellenberger E, Kovács R, Heinemann U, Friedman A.

J Cereb Blood Flow Metab. 2014 Nov;34(11):1791-801. doi: 10.1038/jcbfm.2014.147. Epub 2014 Aug 27.

15.

Direct coupling of annexin A5 to VSOP yields small, protein-covered nanoprobes for MR imaging of apoptosis.

Figge L, Appler F, Chen HH, Sosnovik DE, Schnorr J, Seitz O, Taupitz M, Hamm B, Schellenberger E.

Contrast Media Mol Imaging. 2014 Jul-Aug;9(4):291-9. doi: 10.1002/cmmi.1575.

PMID:
24706613
16.

XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.

Haeckel A, Appler F, Figge L, Kratz H, Lukas M, Michel R, Schnorr J, Zille M, Hamm B, Schellenberger E.

J Nucl Med. 2014 Mar;55(3):508-14. doi: 10.2967/jnumed.113.128108. Epub 2014 Feb 18.

17.

ZC4H2 mutations are associated with arthrogryposis multiplex congenita and intellectual disability through impairment of central and peripheral synaptic plasticity.

Hirata H, Nanda I, van Riesen A, McMichael G, Hu H, Hambrock M, Papon MA, Fischer U, Marouillat S, Ding C, Alirol S, Bienek M, Preisler-Adams S, Grimme A, Seelow D, Webster R, Haan E, MacLennan A, Stenzel W, Yap TY, Gardner A, Nguyen LS, Shaw M, Lebrun N, Haas SA, Kress W, Haaf T, Schellenberger E, Chelly J, Viot G, Shaffer LG, Rosenfeld JA, Kramer N, Falk R, El-Khechen D, Escobar LF, Hennekam R, Wieacker P, Hübner C, Ropers HH, Gecz J, Schuelke M, Laumonnier F, Kalscheuer VM.

Am J Hum Genet. 2013 May 2;92(5):681-95. doi: 10.1016/j.ajhg.2013.03.021. Epub 2013 Apr 25.

18.

Certain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to stroke.

Harms C, Datwyler AL, Wiekhorst F, Trahms L, Lindquist R, Schellenberger E, Mueller S, Schütz G, Roohi F, Ide A, Füchtemeier M, Gertz K, Kronenberg G, Harms U, Endres M, Dirnagl U, Farr TD.

J Cereb Blood Flow Metab. 2013 May;33(5):e1-9. doi: 10.1038/jcbfm.2013.22. Epub 2013 Feb 27.

19.

Imaging of magnetic microfield distortions allows sensitive single-cell detection.

Lindquist RL, Papazoglou S, Scharlach C, Waiczies H, Schnorr J, Taupitz M, Hamm B, Schellenberger E.

Mol Imaging. 2013 Mar-Apr;12(2):83-9.

PMID:
23415396
20.

Combined in situ zymography, immunofluorescence, and staining of iron oxide particles in paraffin-embedded, zinc-fixed tissue sections.

Haeckel A, Schoenzart L, Appler F, Schnorr J, Taupitz M, Hamm B, Schellenberger E.

Mol Imaging. 2012 Sep-Oct;11(5):383-8.

PMID:
22954182
21.

Straightforward thiol-mediated protein labelling with DTPA: Synthesis of a highly active 111In-annexin A5-DTPA tracer.

Kratz H, Haeckel A, Michel R, Schönzart L, Hanisch U, Hamm B, Schellenberger E.

EJNMMI Res. 2012 Apr 27;2(1):17. doi: 10.1186/2191-219X-2-17.

22.

Electrostatically Stabilized Magnetic Nanoparticles - An Optimized Protocol to Label Murine T Cells for in vivo MRI.

Wuerfel E, Smyth M, Millward JM, Schellenberger E, Glumm J, Prozorovski T, Aktas O, Schulze-Topphoff U, Schnorr J, Wagner S, Taupitz M, Infante-Duarte C, Wuerfel J.

Front Neurol. 2011 Dec 16;2:72. doi: 10.3389/fneur.2011.00072. eCollection 2011.

23.

Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.

Schnorr J, Taupitz M, Schellenberger EA, Warmuth C, Fahlenkamp UL, Wagner S, Kaufels N, Wagner M.

Rofo. 2012 Feb;184(2):105-12. doi: 10.1055/s-0031-1281982. Epub 2011 Dec 16.

PMID:
22179768
24.

Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.

Wagner M, Wagner S, Schnorr J, Schellenberger E, Kivelitz D, Krug L, Dewey M, Laule M, Hamm B, Taupitz M.

J Magn Reson Imaging. 2011 Oct;34(4):816-23. doi: 10.1002/jmri.22683. Epub 2011 Jul 18.

PMID:
21769977
25.

Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining.

Bahmani P, Schellenberger E, Klohs J, Steinbrink J, Cordell R, Zille M, Müller J, Harhausen D, Hofstra L, Reutelingsperger C, Farr TD, Dirnagl U, Wunder A.

J Cereb Blood Flow Metab. 2011 May;31(5):1311-20. doi: 10.1038/jcbfm.2010.233. Epub 2011 Jan 19.

26.

Bioresponsive nanosensors in medical imaging.

Schellenberger E.

J R Soc Interface. 2010 Feb 6;7 Suppl 1:S83-91. doi: 10.1098/rsif.2009.0336.focus. Epub 2009 Oct 21. Review.

27.

Protease-specific nanosensors for magnetic resonance imaging.

Schellenberger E, Rudloff F, Warmuth C, Taupitz M, Hamm B, Schnorr J.

Bioconjug Chem. 2008 Dec;19(12):2440-5. doi: 10.1021/bc800330k.

PMID:
19007261
28.

Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis.

Schellenberger E, Schnorr J, Reutelingsperger C, Ungethüm L, Meyer W, Taupitz M, Hamm B.

Small. 2008 Feb;4(2):225-30. doi: 10.1002/smll.200700847.

PMID:
18203233
29.

Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.

Morawietz H, Rohrbach S, Rueckschloss U, Schellenberger E, Hakim K, Zerkowski HR, Kojda G, Darmer D, Holtz J.

Eur J Clin Invest. 2006 Oct;36(10):705-12.

PMID:
16968466
30.

Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.

Schnorr J, Wagner S, Abramjuk C, Drees R, Schink T, Schellenberger EA, Pilgrimm H, Hamm B, Taupitz M.

Radiology. 2006 Jul;240(1):90-100. Epub 2006 May 9.

PMID:
16684917
31.

[Applications of optical imaging].

Schellenberger E.

Z Med Phys. 2005;15(3):187-91. German.

PMID:
16171040
32.

Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle.

Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L.

Magn Reson Med. 2005 Sep;54(3):718-24.

33.

Quantitative analysis of chemotherapeutic effects in tumors using in vivo staining and correlative histology.

Choi HK, Yessayan D, Choi HJ, Schellenberger E, Bogdanov A, Josephson L, Weissleder R, Ntziachristos V.

Cell Oncol. 2005;27(3):183-90.

34.

Methotrexate-induced accumulation of fluorescent annexin V in collagen-induced arthritis.

Wunder A, Schellenberger E, Mahmood U, Bogdanov A Jr, Müller-Ladner U, Weissleder R, Josephson L.

Mol Imaging. 2005 Jan-Mar;4(1):1-6.

PMID:
15967121
35.

Magneto/optical annexin V, a multimodal protein.

Schellenberger EA, Sosnovik D, Weissleder R, Josephson L.

Bioconjug Chem. 2004 Sep-Oct;15(5):1062-7.

PMID:
15366960
36.

Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.

Schnorr J, Wagner S, Abramjuk C, Wojner I, Schink T, Kroencke TJ, Schellenberger E, Hamm B, Pilgrimm H, Taupitz M.

Invest Radiol. 2004 Sep;39(9):546-53.

PMID:
15308937
37.

Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate.

Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov A Jr, Josephson L, Weissleder R.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12294-9. Epub 2004 Aug 10.

38.

Surface-functionalized nanoparticle library yields probes for apoptotic cells.

Schellenberger EA, Reynolds F, Weissleder R, Josephson L.

Chembiochem. 2004 Mar 5;5(3):275-9.

PMID:
14997519
39.

Optimal modification of annexin V with fluorescent dyes.

Schellenberger EA, Weissleder R, Josephson L.

Chembiochem. 2004 Mar 5;5(3):271-4.

PMID:
14997518
40.

Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.

Schellenberger EA, Bogdanov A Jr, Högemann D, Tait J, Weissleder R, Josephson L.

Mol Imaging. 2002 Apr-Jun;1(2):102-7.

PMID:
12920851
41.

Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.

Schellenberger EA, Bogdanov A Jr, Petrovsky A, Ntziachristos V, Weissleder R, Josephson L.

Neoplasia. 2003 May-Jun;5(3):187-92. doi: 10.1016/S1476-5586(03)80050-7.

42.

Near-infrared fluorescent imaging of tumor apoptosis.

Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr.

Cancer Res. 2003 Apr 15;63(8):1936-42.

43.

Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.

Schellenberger EA, Högemann D, Josephson L, Weissleder R.

Acad Radiol. 2002 Aug;9 Suppl 2:S310-1. No abstract available.

PMID:
12188257
44.

Imaging features of iliopsoas bursitis.

Wunderbaldinger P, Bremer C, Schellenberger E, Cejna M, Turetschek K, Kainberger F.

Eur Radiol. 2002 Feb;12(2):409-15. Epub 2001 Sep 15.

PMID:
11870443
45.

[The rats nibble on the plaster cast].

Schellenberger E.

Krankenpfl J. 1982 Apr 15;20(4):26. German. No abstract available.

PMID:
6918648

Supplemental Content

Loading ...
Support Center